CJC-1295 with DAC (Long-Acting GHRH Analog)

CJC-1295 with DAC is an experimental synthetic peptide classified as a GHRH (Growth Hormone-Releasing Hormone) analog, primarily investigated for its effects on pituitary growth hormone secretion and related endocrine signaling pathways.

A key structural feature of CJC-1295 is the incorporation of a Drug Affinity Complex (DAC). This modification is designed to promote prolonged association with circulating albumin, extending the compound’s pharmacokinetic profile and duration of biological activity compared with shorter-acting GHRH-related peptides.

In endocrine research, CJC-1295 with DAC is studied in connection with GHRH receptor activation, pituitary GH secretion, the GH/IGF-1 axis, pulsatile growth hormone signaling, and associated metabolic and endocrine regulatory mechanisms.

It can also serve as a research tool for comparing long-acting GHRH analogs with native GHRH and related research peptides in terms of signaling duration, receptor activity, and endocrine responses.

CJC-1295 with DAC remains an investigational compound and is not an approved treatment for muscle enhancement, fat loss, anti-aging, or athletic performance. Experimental findings should therefore not be interpreted as established human benefits.

La livraison est facturée selon le nombre d'articles de la commande, aux mêmes tarifs pour toutes les destinations, et le montant exact s'affiche au moment du paiement, avant de payer. Expédition sous 1 jour ouvré.

Pas convaincu ? Renvoyez le produit sous 30 jours pour un remboursement intégral, même ouvert.